The Time for the Reemergence of This Great Company is NOW
Products on Retail Shelves by 01/01/2013!!
A company with products that to date have generated over $3,000,000 of revenues in years past
is now ready to reestablish its presence in former retail locations:
Walmart
Walgreens
CVS
CVS Caremark
Target
Safeway
Kroger
The US Army/USAF Exchange
And Many More...
StemIntense and Snorenze available to order online now!
Link to MedGen's Online Store:
http://www.northstargbs.com/
MDIN Product List
- Snorenz
- Good Night's Sleep
- Painenz
- StemIntense Product Line
**Snorenz Patent**
MDIN Estimates 17,000,000 Units to Sell in 2013
- Snorenz = 12,000,000 Units
- Good Night's Sleep = 10,000,000 Units
- Painenz = Projections not out yet
- StemIntense Product Line = Projections not out yet
StemIntense Product Line
- Revolutionary Stem Cell Product to be sold in retail chains across the U.S.
- Goal is to get products on shelves by 01/01/2013
- Goal is to take 35%-45% market share of the $2.7 billion industry
http://www.medgeninc.com/stemintense/
Website: www.medgeninc.com
Email: otc@northstarbb.com
Twitter: www.twitter.com/MedGenInc
Outstanding Shares: 402,319,415 a/o February 28th, 2013
Public Float: 238,086,932 a/o February 28th, 2013
Promise of No Dilution for 12-24 Months:
"My promise is that there will be NO dilution in the next 12 to 24 months. It's off the table, period." He said also stating that the company did plan to reduce the number of authorized shares as part of a plan to tighten up Northstar's equity profile.
1) Products on retail shelves by 01/01/2013
2) Details on revolutionary stem cell product
3) Reducing of Authorized Shares
4) Share buyback to decrease Outstanding Shares
5) Unit sales projections of Painenz and new stem cell product for 2013
6) Q1 2013 financial report
7) Uplisting to higher markets MDIN's 2013 Pro Forma Sales Forecast 